Reviews on Clinical Pharmacology and Drug TherapyReviews on Clinical Pharmacology and Drug TherapyОбзоры по клинической фармакологии и лекарственной терапии1683-41002542-1875Eco-Vector80210.17816/RCF1233-12ArticlesСтатьиNeuropeptide vasopressin and memory processНейропептид вазопрессин и процессы памятиBelokoskovaSvetlana GeorgiyevnaБелокосковаСветлана Георгиевна

PhD (Medicine)

к. м. н., старший научный сотрудник лаборатории психофизиологии эмоций

belokoskova.s@yandex.ruTsikunovSergey GeorgiyevichЦикуновСергей Георгиевич

Doctor of Medical Sciences, Professor, Head, Laboratory of Psychophysiology of Emotions

д. м. н., профессор, заведующий лабораторией психофизиологии эмоций

secikunov@yandex.ruInstitute of Experimental Medicine, NWB RAMSФГБУ «Научно-исследовательский институт экспериментальной медицины» СЗО РАМН15092014123VOL 12, NO3 (2014)ТОМ 12, №3 (2014)31221102015Copyright ©; 2014, Belokoskova S.G., Tsikunov S.G.Copyright ©; 2014, Белокоскова С.Г., Цикунов С.Г.2014Belokoskova S.G., Tsikunov S.G.Белокоскова С.Г., Цикунов С.Г.http://creativecommons.org/licenses/by/4.0https://journals.eco-vector.com/RCF/article/view/802

The contemporary information about participation of neuropeptide arginin-vasopressin and its receptors in memory processes in normal and pathology processes both in animals and human beings are present in this review. The own investigational results about influence of agonist of V2 receptors of vasopressin on verbal memory and learning at patients with stroke are added too.

В обзоре представлены современные сведения об участии нейропептида аргинин-вазопрессина и отдельных его рецепторов в регуляции различных видов памяти у животных и человека в норме и при патологии. Приведены результаты собственного исследования влияния агониста V2 рецепторов вазопрессина на вербальную память у больных с инсультами.

vasopressinmemorystrokeвазопрессинпамятьинсультАнохин К. В. Молекулярные сценарии консолидации долговременной памяти // Журн. высш. нервной деятельности им. И. П. Павлова. - 1997. - Т. 47, № 2. - С. 261-279.Бахарев В. Д. Клиническая нейрофизиология регуляторных пептидов. - Cвердловск: Из-во Уральского Университета. - 1989. - C. 35-42.Белокоскова C. Г., Цикунов С. Г. Агонист V2 рецепторов вазопрессина, 1-дезамино-8-D-аргинин-вазопрессин, редуцирует симптомы паркинсонизма // Обзоры по клин. фармакол. и лек. терапии. - 2013. - Т. 11, № 4. - C. 61-67.Белокоскова С. Г., Степанов И. И., Цикунов С. Г. Агонист V2-рецепторов вазопрессина редуцирует депрессивные расстройства у постинсультных больных // Вестник РАМН. - 2012. - № 4. - С. 40-44.Белокоскова С. Г., Цикунов С. Г. Влияние селективного агониста V2 рецепторов вазопрессина на мозговой кровоток у больных в отдаленном периоде инсульта // Мед. акад. журн. - 2012. - Т. 12, № 1. - С. 73-79.Белокоскова С. Г., Цикунов С. Г., Клементьев Б. И. Нейропептидная индукция компенсаторных процессов при афазиях // Вестник РАМН. - 2002. - № 9. - C. 28-32.Гомазков О. А. Нейротрофические и ростовые факторы мозга: регуляторная специфика и терапевтический потенциал // Успехи физиол. наук. - 2005. - Т 36, № 2. - С. 27.Гомазков О. А. Сигнальные молекулы как регуляторы нейрогенеза взрослого мозга // Нейрохимия. - 2013. - Т. 30, № 4. - C. 273-288.Гомазков О. А. Функциональная биохимия регуляторных пептидов. М. ВО «Наука». - 1992.Молодцова Г. Ф. Различная роль дофамина и серотонина в процессе воспроизведения условной реакции пассивного избегания у крыс // Журн. высш. нервной деятельности им. И. П. Павлова. - 2006. - Т. 56, № 2. - С. 242-246.Стаховская Л. В. Память и её нарушения // Журн. неврол. и психиатрии им. С. С. Корсакова. - 2000. - Т. 100, № 7. - С. 45-49.Степанов И. И., Гаврилова И. В., Лосев Н. А., Сапронов Н. С., и др. Методология изучения памяти при фармакологической коррекции ее нарушений у больных алкоголизмом, перенесших черепно-мозговую травму // Обзоры по клин. фармакол. и лек. терапии. - 2012. - Т. 10, № 1. - С. 39-46.Степанов И. И., Даниловский М. М., Ефремов О. М., и др. Информативность математической модели процесса обучения // Информационно-управляющие системы. - 2011. - № 1. - C. 34-40.Телегди Г., Ковач Г. Л. Влияние вазопрессина и окситоцина на поведенческие процессы и метаболизм нейротрансмиттеров мозга у крыс // Проблемы эндокринологии - 1980. - Т 26, № 6. - C. 37-41.Цикунов С. Г., Белокоскова С. Г. Роль вазопрессина в регуляции функций ЦНС // Мед. акад. журн. - 2010. - Т. 10, № 4. - С. 218-228.Beckwith B. E., Petros T. V., Bergloff P. J. et al. Failure of posttrial administration of vasopressin analogue (DDAVP) to influence memory in healthy, young, male volunteers // Peptides. - 1995. - Vol. 16, N 8. - P. 1327-1328.Beckwith B. E., Till R. E., Schneider V. Vasopressin analog (DDAVP) improves memory in human males // Peptides. - 1984. - Vol. 5, N 4. - P. 819-822.Biegon A., Terlou M., Voorhuis Th D., De Kloet E. R. Arginine-vasopressin binding sites in rat brain: a quantitative autoradiographic study // Neurosci Lett. - 1984. - Vol. 44, N 3. - P. 229-234.Bielsky I. F., Hu S. B., Ren X. et al. The V1a vasopressin receptor is necessary and sufficient for normal social recognition: a gene replacement study // Neuron. - 2005. - Vol. 47, N 4. - P. 503-513.Bielsky I. F., Hu S. B., Szegda K. L., et al. Profound impairment in social recognition and reduction in anxiety-like behavior in vasopressin V1a receptor knockout mice // Neuropsychopharmacology. - 2004. - Vol. 29, N 3. - P. 483-493.Bohus B., Kovács G. L., de Wied D. Oxytocin, vasopressin and memory: opposite effects on consolidation and retrieval processes // Brain Res. - 1978. - Vol. 157, N 2. - P. 414-417.Brambilla F., Aguglia E., Massironi R., et al. Neuropeptide therapies in chronic schizophrenia: TRH and vasopressin administration // Neuropsychobiology. - 1986. - Vol. 15, N 3-4. - P. 114-121.Brambilla F., Bondiolotti G. P., Maggioni M., et al. Vasopressin (DDAVP) therapy in chronic schizophrenia: effects on negative symptoms and memory // Neuropsychobiology. - 1989. - Vol. 20, N 3. - P. 113-119.Brinton R. D., Monreal A. W., Fernandez J. G. Vasopressin-induced neurotrophism in cultured hippocampal neurons via V1 receptor activation // J Neurobiol. - 1994. - Vol. 25, N 4. - P. 380-394.Bruins J., Kovács G. L., Abbes A. P., et al. Minor disturbances in central nervous system function in familial neurohypophysial diabetes insipidus // Psychoneuroendocrinology. - 2006. - Vol. 31, N 1. - P. 80-91.Buijs R. M. Intra- and extrahypothalamic vasopressin and oxytocin pathways in the rat. Pathways to the limbic system, medulla oblongata and spinal cord // Cell Tissue Res. - 1978. - Vol. 192, N 3. - P. 423-435.Chen Q., Patel R., Sales A., et al. Vasopressin-induced neurotrophism in cultured neurons of the cerebral cortex: dependency on calcium signaling and protein kinase C activity // Neuroscience. - 2000. - Vol. 101, N 1. - P. 19-26.Couk D. I., Beckwith B. E. Effect of desmopressin acetate (DDAVP) on learning of a brightness discrimination // Peptides. - 1982. - Vol. 3, N 3. - P. 521-526.Dantzer R., Bluthé R. M. Vasopressin involvement in antipyresis, social communication, and social recognition: a synthesis // Crit. Rev. Neurobiol. - 1992. - Vol. 6, N 4. - P. 243-255.Dantzer R., Bluthe R. M., Koob G. F., Le Moal M. Modulation of social memory in male rats by neurohypophyseal peptides // Psychopharmacology. - 1987. - N 91. - P. 363-368.De Vito L. M., Konigsberg R., Lykken C., et al. Vasopressin 1b receptor knock-out impairs memory for temporal order // J Neurosci. - 2009. - Vol. 29, N 9. - P. 2676-2683.De Wied D. Long term effect of vasopressin on the maintenance of a conditioned avoidance response in rats // Nature. - 1971. - Vol. 232, N 5305. - P. 58-60.De Wied D. The influence of the posterior and intermediate lobe of the pituitary and pituitary peptides on the maintenance of a conditioned avoidance response in rats // Int. J. Neuropharmacol. - 1965. - N 4. - P. 157-167.De Wied D., Diamant M., Fodor M. Central nervous system effects of the neurohypophyseal hormones and related peptides // Front. Neuroendocrinol. - 1993. - Vol. 14, N 4. - P. 251-302.Delwaide P. J., Devoitille J. M., Ylieff M. Acute effect of drugs upon memory of patients with senile dementia // Acta Psychiatr Belg. - 1980. - Vol. 80, N 5. - P. 748-754.Egashira N., Mishima K., Iwasaki K., et al. New topics in vasopressin receptors and approach to novel drugs: role of the vasopressin receptor in psychological and cognitive functions // J Pharmacol. Sci. - 2009. - Vol. 109, N 1. - P. 44-49.Egashira N., Tanoue A., Higashihara F., et al. V1a receptor knockout mice exhibit impairment of spatial memory in an eight-arm radial maze // Neurosci. Lett. - 2004. - N 356. - P. 195-198.Eisenberg J., Hamburger-Bar R., Belmaker R. H. The effect of vasopressin treatment on learning in Down's syndrome // J. Neural. Transm. - 1984. - Vol. 60, N 2. - P. 143-147.Engelmann M., Landgraf R. Microdialysis administration of vasopressin into the septum improves social recognition in Brattleboro rats // Physiol Behav. - 1994. - N 55. - P. 145-149.Ettenberg A., Le Moal M., Koob G. F. et al. Vasopressin reversal by a pressor antagonist analog of vasopressin // Pharmacol Biochem Behav. - 1983. - Vol. 18, N 4. - P. 645-647.Faiman C. P., de Erausquin G. A., Baratti C. M. Modulation of memory retrieval by pre-testing vasopressin: involvement of a central cholinergic nicotinic mechanism // Methods Find Exp. Clin. Pharmacol. - 1992. - Vol. 14, N 8. - P. 607-613.Fehm-Wolfsdorf G., Bachholz G., Born J., et al. Vasopressin but not oxytocin enhances cortical arousal: an integrative hypothesis on behavioral effects of neurohypophyseal hormones // Psychopharmacology (Berl). - 1988. - Vol. 94, N 4. - P. 496-500.Ferguson J. N., Young L. J., Insel T. R. The neuroendocrine basis of social recognition // Front Neuroendocrinol. - 2002. - N 23. - P. 200-224.Fliers E., De Vries G. J., Swaab D. F. Changes with aging in the vasopressin and oxytocin innervation of the rat brain // Brain Res. - 1985. - Vol. 348, N 1. - P. 1-8.Fliers E., Swaab D. F., Pool C. W., Verver R. W. The vasopressin and oxytocin neurons in the human sypraoptic and paraventricular nucleus; changes with aging and in senile demention // Brain Res. 1985. - Vol. 342, N 1. - P. 45-53.Giri P. R., Dave J. R., Tabakoff B., Hoffman P. L. Arginine vasopressin induces the expression of c-fos in the mouse septum and hippocampus // Brain Res Mol Brain Res. - 1990. - Vol. 7, N 2. - P. 131-137.Guard O., Marchal G., Graule A. et al. Effects of vasopressin and desmopressin on memory. A double-blind study in 40 healthy volunteers // Neuropsychobiology. - 1986. - Vol. 15, N 2. - P. 80-83.Guastella A. J., Kenyon A. R., Alvares G. A. et al. Intranasal arginine vasopressin enhances the encoding of happy and angry faces in humans // Biol Psychiatry. - 2010. - N 67. - P. 1220-1222.Hamburger-Bar R., Eisenberg J., Belmaker R. H. Animal and clinical studies of vasopressin effects on learning and memory // Isr. J. Med. Sci. - 1987. - Vol. 23, N 1-2. - P. 12-18.Hernando F., Schoots O., Lolait S. J., Burbach J. P. Immunohistochemical localization of the vasopressin V1b receptor in the rat brain and pituitary gland: anatomical support for its involvement in the central effects of vasopressin // Endocrinology. - 2001. - Vol. 142, N 4. - P. 1659-1668.Hirasawa A., Nakayama Y., Ishiharada N., et al. Evidence for the existence of vasopressin V2 receptor mRNA in rat hippocampus // Biochem. Biophys. Res. Commun. - 1994. - Vol. 205, N 3. - P. 1702-1706.Insel T. R. The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior // Neuron. - 2010. - Vol. 65, N 6. - P. 768-779.Insel T. R., Shapiro L. E. Oxytocin receptor distribution reflects social organization in monogamous and polygamous voles // Proc. Natl. Acad. Sci. USA. - 1992. - N 89. - P. 5981-5985.Izquierdo L. A., Schröder N., Ardenghi P. et al. Systemic administration of ACTH or vasopressin reverses the amnestic effect of posttraining beta-endorphin or electroconvulsive shock but not that of intrahippocampal infusion of protein kinase inhibitors // Neurobiol. Learn. Mem. - 1997. - Vol. 68, N 2. - P. 197-202.Jenkins J. S., Mather H. M., Coughlan A. K. Effect of desmopressin on normal and impaired memory // J. Neurol. Neurosurg. Psychiatry. - 1982. - Vol. 45, N 9. - P. 830-831.Jing W., Guo F., Cheng L. et al. Arginine vasopressin prevents amyloid beta protein-induced impairment of long-term potentiation in rat hippocampus in vivo // Neurosci. Lett. - 2009. - Vol. 450, N 3. - P. 306-310.Kato Y., Igarashi N., Hirasawa A. et al. Distribution and developmental changes in vasopressin V2 receptor mRNA in rat brain // Differentiation. - 1995. - Vol. 59, N 3. - P. 163-169.Klimkiewicz T. Memory effects of arginine vasopressin (AVP) and [7-9] fragment of its peptide chain in rats // Acta Neurobiol Exp (Wars). - 2001. - Vol. 61, N 4. - P. 267-276.Koob G. F., Le Moal M., Gaffori O. et al. Arginine vasopressin and a vasopressin antagonist peptide: opposite effects on extinction of active avoidance in rats // Regul. Pept. - 1981. - Vol. 2, N 3. - P. 153-163.Kovacs G. L., Bohus B., Versteeg D. H. et al. Effect of oxytocin and vasopressin on memory consolidation: sites of action and catecholaminergic correlates after local microinjection into limbic-midbrain structures // Brain Res. - 1979. - Vol. 175, N 2. - P. 303-314.Kovács G. L., De Wied D. Peptidergic modulation of learning and memory processes // Pharmacol. Rev. - 1994. - Vol. 46, N 3. - P. 269-291.Kovács G. L., Vécsei L., Medve L. et al. Effect on memory processes of antivasopressin serum microinjected into the dorsal raphe nucleus: the role of catecholaminergic neurotransmission // Exp Brain Res. - 1980. - Vol. 38, N 3. - P. 357-361.Kovács G. L., Vécsei L., Szabó G., Telegdy G. The involvement of catecholaminergic mechanisms in the behavioural action of vasopressin // Neurosci Lett. - 1977. - Vol. 5, N 6. - P. 337-344.Kovács G. L., Veldhuis H. D., Versteed D. H. G., De Wied D. Facilitation of avoidance behavior by vasopressin fragments microinjected into limbic mildbrain of peptides // Annu. Rev. Pharmacol. Taxicol. - 1988. - N 28. - P. 163-188.Koźniewska E., Szczepańska-Sadowska E. V2-like receptors mediate cerebral blood flow increase following vasopressin administration in rats // J Cardiovasc Pharmacol. - 1990. - Vol. 15, N 4. - P. 579-585.Kozorovitskiy Y., Hughes M., Lee K., Gould E. Fatherhood affects dendritic spines and vasopressin V1a receptors in the primate prefrontal cortex // Nat Neurosci. - 2006. - Vol. 9, N 9. - P. 1094-1095.Laczi F., László F. A., Kovács G. L. et al. Differential effect of desglycinamide9- (Arg8)-vasopressin on cognitive functions of diabetes insipidus and alcoholic patients // Acta Endocrinol (Copenh). - 1987. - Vol. 115, N 3. - P. 392-398.Laczi F., Valkusz Z., László F. A. et al. Effects of lysine-vasopressin and 1-deamino-8-D-arginine-vasopressin on memory in healthy individuals and diabetes insipidus patients // Psychoneuroendocrinology. - 1982. - Vol. 7, N 2-3. - P. 185-193.Laczi F., van Ree J. M., Wagner A. et al. Effects of desglycinamide-arginine-vasopressin (DG-AVP) on memory processes in diabetes insipidus patients and non-diabetic subjects // Acta. Endocrinol. (Copenh.). - 1983. - Vol. 102, N 2. - P. 205-212.Landgraf R., Frank E., Aldag J. M. et al. Viral vector-mediated gene transfer of the vole V1a vasopressin receptor in the rat septum: improved social discrimination and active social behavior // Eur J Neurosci. - 2003. - N 18. - P. 403-411.Landgraf R., Gerstberger R., Montkowski A. et al. V1 vasopressin receptor antisense oligodeoxynucleotide into the septum reduced vasopressin binding, social discrimination abilities, and anxiety-related behavior in rats // J Neurosci. - 1995. - N 15. - P. 4250-4258.Le Boef A., Lodge J., Eames P. G. Vasopressin and memory in Korsakoff”s syndrome // Lancet. - 1978. - N 11. - P. 1370.Le Moal M., Dantzer R., Michaud B., Koob G. F. Centrally injected arginine vasopressin (AVP) facilitates social memory in rats // Neurosci Lett. - 1987. - N 77. - P. 353-359.Le Moal M., Dantzer R., Mormede P. et al. Behavioral effects of peripheral administration of arginine vasopressin: a rewiew of our search for a mode of action and a hypothesis // Psychoneuroendocrinology. - 1984. - Vol. 9, N 4. - P. 319-341.Lolait S. J., O'Carroll A., Mahan L. C., et al. Extrapituitary expression of the rat V1b vasopressin receptor gene // Proc Natl Acad Sci USA. - 1995. - N 92. - P. 6783-6787.Ludwig M., Tobin V. A., Callahan M. F. et al. Intranasal application of vasopressin fails to elicit changes in brain immediate early gene expression, neural activity and behavioural performance of rats // J Neuroendocrinol. - 2013. - Vol. 25, N 7. - P. 655-667.Millar K., Jeffcoate W. J., Walder C. P. Vasopressin and memory: improvement in normal short-term recall and reduction of alcohol-induced amnesia // Psychol. Med. - 1987. - Vol. 17, N 2. - P. 335-341.Mishima K., Tsukikawa H., Miura I. et al. Ameliorative effect of NC-1900, a new AVP4-9 analog, through vasopressin V1A receptor on scopolamine-induced impairments of spatial memory in the eight-arm radial maze // Neuropharmacology. - 2003. - Vol. 44, N 4. - P. 541-552.Muramoto K., Hagino-Yamagishi K., Tonosaki K., Kaba H. Accessory olfactory bulb neurons are required for maintenance but not induction of V2R vomeronasal receptor gene expression in vitro // Neurosci. Lett. - 2011. - Vol. 500, N 1. - P. 6-9.Nephew B. C., Bridges R. S. Arginine vasopressin V1a receptor antagonist impairs maternal memory in rats // Physiol Behav. - 2008. - Vol. 95, N 1-2. - P. 182-186.Oliveros J. C., Jandali M. K., Timsit-Berthier M. et al. Vasopressin in amnesia // Lancet. - 1978. - N 1. - P. 42.Ostrowski N. L., Lolait S. J., Bradley D. J., et al. Distribution of V1a and V2 vasopressin receptor messenger ribonucleic acids in rat liver, kidney, pituitary and brain // Endocrinology. - 1992. - Vol. 131, N 1. - P. 533-535.Ostrowski N. L., Lolait S. J., Young W. S. 3rd. Cellular localization of vasopressin V1a receptor messenger ribonucleic acid in adult male rat brain, pineal, and brain vasculature // Endocrinology. - 1994. - Vol. 135, N 4. - P. 1511-1528.Perras B., Droste C., Born J. et al. Verbal memory after three months of intranasal vasopressin in healthy old humans // Psychoneuroendocrinology. - 1997. - Vol. 22, N 6. - P. 387-396.Pietrowsky R., Fehm-Wolfsdorf G., Born J., Fehm H. L. Effects of DGAVP on verbal memory // Peptides. - 1988. - Vol. 9, N 6. - P. 1361-1366.Ramanathan G., Cilz N. I., Kurada L. et al. Vasopressin facilitates GABAergic transmission in rat hippocampus via activation of V (1A) receptors // Neuropharmacology. - 2012. - Vol. 63, N 7. - P. 1218-1226.Reijmers L. G., van Ree J. M., Spruijt B. M., Burbach J. P., De Wied D. Vasopressin metabolites: a link between vasopressin and memory? // Prog Brain Res. - 1998. - N 119. - P. 523-535.Ring R. H. The central vasopressinergic system: examining the opportunities for psychiatric drug development // Curr. Pharm. Des. - 2005. - Vol. 11, N 2. - P. 205-225.Sahgal A. A critique of the vasopressin-memory hypothesis // Psychopharmacology (Berl). - 1984. - Vol. 83, N 3. - P. 215-228.Schwarzberg H., Kovács G. L., Szabó G., Telegdy G. Intraventricular administration of vasopressin and oxytocin effects the steady-state levels of serotonin, dopamine and norepinephrine in rat brain // Endocrinol Exp. - 1981. - Vol. 15, N 2. - P. 75-80.Skopkova J., Croiset G., De Wied D. Differential effects of DGAVP on acquisition and extinction of active avoidance behavior // Peptides. - 1991. - Vol. 12, N 3. - P. 471-475.Stoop R. Neuromodulation by oxytocin and vasopressin // Neuron. - 2012. - N 76. - P. 142-59.Tobin V. A., Hashimoto H., Wacker D. W. et al. An intrinsic vasopressin system in the olfactory bulb is involved in social recognition // Nature. - 2010. - Vol. 464, N 7287. - P. 413-417.Tribollet E., Barberis C., Jard S., et al. Localization and pharmacological characterization of high affinity binding sites for vasopressin and oxytocin in the rat brain by light microscopic autoradiography // Brain Res. - 1988. - Vol. 442, N 1. - P. 105-118.Tsikunov S. G., Belokoskova S. G. Psychophysiological analisis of the influence of vasopressin on speech in patients with post-stroke aphasias // Span. J. Psychol. - 2007. - Vol. 10, N 1. - P. 178-188.Vaccari C., Lolait S. J., Ostrowski N. L. Comparative distribution of vasopressin V1b and oxytocin receptor messenger ribonucleic acids in brain // Endocrinology. - 1998. - Vol. 139, N 12. - P. 5015-5033.van Heuven-Nolsen D., De Kloet E. R., De Wied D., Versteeg D. H. Microinjection of vasopressin and two related peptides into the amygdala: enhancing effect on local dopamine neurotransmission // Brain Res. - 1984. - Vol. 293, N 1. - P. 191-195.van Wimersma Greidanus T. B., Baars A. Physiological role of endogenous vasopressin and oxitocin in learning behavior // J. Endocrinol. Invest. - 1991. - N 14 (suppl. 4). - P. 161.van Wimersma Greidanus T. B., Maigret C. The role of limbic vasopressin and oxytocin in social recognition // Brain Res. - 1996. - N 713. - P. 153-159.Vargas K. J., Sarmiento J. M., Ehrenfeld P. et al. Postnatal expression of V2 vasopressin receptor splice variants in the rat cerebellum // Differentiation. - 2009. - Vol. 77, N 4. - P. 377-385.Wacker D. W., Tobin V. A., Noack J. et al. Expression of early growth response protein 1 in vasopressin neurones of the rat anterior olfactory nucleus following social odour exposure // J. Physiol. - 2010. - N 588 (Pt. 23). - P. 4705-4717.Weingartner H., Gold P., Ballenger J. C. et al. Effects of vasopressin on human memory functions // Science. - 1981. - Vol. 211, N 4482. - P. 601-603.Wersinger S. R., Ginns E. I., O'Carroll A. M. et al. Vasopressin V1b receptor knockout reduces aggressive behavior in male mice // Mol. Psychiatry. - 2002. - Vol. 7, N 9. - P. 975-984.Wu P. H., Lança A. J., Liu J. F. et al. Peripheral injection of arginine8-vasopressin increases Fos in specific brain areas // Eur J Pharmacol. - 1995. - Vol. 281, N 3. - P. 263-269.Young L. J., Murphy Young A. Z., Hammock E. A. Anatomy and neurochemistry of the pair bond // J. Comp. Neurol. - 2005. - N 493. - P. 51-57.Young L. J., Nilsen R., Waymire K. G. et al. Increased affiliative response to vasopressin in mice expressing the V1a receptor from a monogamous vole // Nature. - 1999. - N 400. - P. 766-768.Young L. J., Winslow J. T., Nilsen R., Insel T. R. Species differences in V1a receptor gene expression in monogamous and nonmonogamous voles: behavioral consequences // Behav. Neurosci. - 1997. - N 111. - P. 599-605.Zenina T. A., Gudasheva T. A., Bukreyev Y. S., Seredenin S. B. Neuroprotective effect of dipeptide AVP (4-5)-NH2 is associated with nerve growth factor and heat shock protein HSP70 // Bull. Exp. Biol. Med. - 2007. - Vol. 144, N 4. - P. 543-545.Zhou A. W., Guo J., Wang H. Y., et al. Enhancement of NGF gene expression in rat brain by the memory-enhancing peptide AVP (4-8) // Peptides. - 1995. - Vol. 16, N 4. - P. 581-586.Zhou A. W., Li W. X., Guo J., Du Y. C. Facilitation of AVP (4-8) on gene expression of BDNF and NGF in rat brain // Peptides. - 1997. - Vol. 18, N 8. - P. 1179-1187.Zink C. F., Kempf L., Hakimi S. et al. Vasopressin modulates social recognition-related activity in the left temporoparietal junction in humans // Transl. Psychiatry. - 2011. - N 1. - P. e3.